PROSPECTO : INFORMATION FOR THE USER
Loratadine 10 mg tablets EFG
Read this prospect carefully before starting to take the medicine.
LORATADINA pensabelongs to a class of medicines known as antihistamines.
LORATADINA pensarelieves symptoms associated with allergic rhinitis (such as sneezing, runny or itchy nose and eye itching or burning).
LORATADINA pensacan also be used to help relieve symptoms of urticaria (such as itching, redness and the number and size of skin hives).
Do not take LORATADINAif:
Be especially careful with LORATADINAif:
Use of other medications:
No interactions ofLORATADINAwith other medications are known. However, inform your doctor or pharmacist if you are using or have recently used other medications, including those acquired without a prescription.
Taking LORATADINAwith food and beverages
LORATADINAcan be taken with or without food.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before taking a medication.
It is not recommended that you takeLORATADINAif you are pregnant or breastfeeding.
Driving and operating machines
At normal doses,LORATADINAdoes not affect the ability to drive or operate machines. If you experience drowsiness symptoms, do not drive or operate machines, however, try not to perform tasks that require special attention until you know how you tolerate the medication.
Important information about some of the components of LORATADINA:
This medication contains lactose. If your doctor has indicated that you have a certain sugar intolerance, consult with him before taking this medication.
Follow these instructions unless your doctor has given you different instructions.
Remember to take your medication
Your doctor will tell you the duration of treatment withLORATADINApensaDo not stop treatment before.
Adults and children over 2 years of age with a weight of more than 30 kg:
Take one tablet (10 mg) once a day.
Patients with severe liver problems with a weight of more than 30 kg:
Take one tablet (10 mg) once a day and on alternate days.
LORATADINApensa10 mg tablets are not suitable for:
It is not recommended to takeLORATADINApensain children under 2 years of age.
If you take more LORATADINApensathan you should:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Tel (91) 562 04 20, indicating the medication and the amount ingested.
If you forgot to take LORATADINApensa:
If you forgot to take your dose on time, take it as soon as possible, and then return to your usual dosing schedule. Do not take a double dose to make up for the missed doses.
Like all medications,LORATADINAmayproduce adverse effects, although not all people will experience them.
The most frequently reported adverse effects (less than 1 in 10 patients but more than 1 in 100 patients) include drowsiness, headache, nervousness, fatigue, increased appetite, and difficulty sleeping.
Very rare adverse effects (less than 1 in 10,000 patients) have been reported cases of severe allergic reaction, dizziness, irregular or rapid heartbeats, nausea (urge to vomit), dry mouth, upset stomach, liver problems, hair loss, skin rash, and fatigue.
If you consider any of the adverse effects you are experiencing to be severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
Keep out of the reach and sight of children.
Expiration Date
Do not useLORATADINAtabletsafter the expiration date indicated on the carton and in the blister pack.
Do not useLORATADINAtabletsif you observe any change in the appearance of the tablet.
Storage Conditions
No special storage conditions are required.
Loratadine pensa Composition
Product Appearance and Packaging Contents
Loratadine pensa 10 mg is presented in the form of tablets. Each package contains 20 tablets in a blister.
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Responsible for Manufacturing
PHARMEX ADVANCED LABORATORIES S.L.
Ctra. A-431 Km.19
14720 Almodóvar del Río (Córdoba)
Spain
or
INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A
Laguna, 66-68-70. Poligono Industrial Urtinsa II
Alcorcón (Madrid) - 28923 – Spain
This leaflet was approved in September 2004
Last review: February 2010
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.